New shot aims to block pain for days after lung surgery
NCT ID NCT07432711
Summary
This study is testing if a new, long-acting numbing medicine (liposomal bupivacaine) works better than the standard numbing medicine when injected into the surgical cuts after minimally invasive lung surgery. Researchers want to see if it reduces pain and the need for strong painkillers like morphine in the first few days after the operation. The trial will involve 100 adults having this type of surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.